GPX4 and ovarian neoplasm: The presence of 4-HNE facilitates the carbonylation modification of cysteine residue 93 in GPX4, thereby attenuating the interaction between ovarian tumor (OTU) deubiquitinase 5 (OTUD5) and GPX4, and promoting the ubiquitination-mediated degradation of GPX4 (116).